A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis
Cholestatic pruritus in PSC has a major adverse impact on QoL, interferes with daily activities, and is inadequately treated in the majority of respondents. These unmet needs highlight the importance of developing safe/effective antipruritic treatments for PSC.
Authors
- Kerrie Goldsmith
- Pamela Vig (ORCID: https://orcid.org/0009-0000-4226-5435)
- Will Garner (ORCID: https://orcid.org/0000-0003-0738-8696)
- Sindee Weinbaum
- Martine Walmsley (ORCID: https://orcid.org/0000-0003-4622-5590)
- Rachel Gomel
- Julio A. Burman
- Jolan Terner-Rosenthal
- Andrew McKibben (ORCID: https://orcid.org/0009-0006-7206-6676)
- Ricky Safer
- Kris V. Kowdley (ORCID: https://orcid.org/0000-0002-8553-3652)
- Tiago F. Nunes
- Joanne Hatchett
Institutions
- Washington State University Spokane (US)
- Israel Medical Association (IL)
- Liver Institute Northwest (US)
- Program Support Center (US)
- PSC Partners Seeking a Cure (US)
- Georgia Highlands College (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1097/hc9.0000000000000904
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00